ORTEXORTEX News
Tracking LXRX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
LX

Lexicon Pharmaceuticals, Inc. (LXRX) short interest & options flow

NASDAQ

Lexicon Pharmaceuticals heads into its November 6 earnings report with short sellers backing away from one of the more heavily shorted small-cap biotech names, even as an activist investor holds nearly two-fifths of the company. The short-side retreat is the week's clearest signal. Short interest has dropped 6.7% over the past week to 6.6% of free float, and is down more than 20%…

$1.61+8.78% 1d+8.78% 1w-7.47% 1mClose: 5 Nov 2026
Cost to borrow
Low
Live CTB on ORTEX →
Market cap
$792M
Next earnings
5 Mar 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 7 Nov 2026

ORTEX chart of Lexicon Pharmaceuticals, Inc. (LXRX) share price and short interest (% of free float), six months to November 5, 2026

LXRX news and analysis

RSS

No long-form analysis yet for LXRX. Pulse alerts and the live data picture are available on ORTEX.

Open LXRX on ORTEX →

Want the live picture for LXRX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LXRX — free to start on ORTEX.

Sign up for free →Open LXRX on ORTEX